NASDAQ: SRZNSurrozen Inc Stock Ownership - Who owns Surrozen?
Insider buying vs selling
Have Surrozen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Charles O. Williams | CFO and COO | 2025-06-13 | 400 | $8.06 | $3.22kBuy |
| Yang Li | Exec. Vice President Research | 2025-06-13 | 400 | $8.06 | $3.22kBuy |
| Craig C. Parker | Chief Executive Officer | 2025-06-13 | 400 | $8.06 | $3.22kBuy |
| Column Group III GP LP | 10% Owner | 2025-03-26 | 323,886 | $11.60 | $3.76MBuy |
| Column Group III GP LP | 10% Owner | 2025-03-26 | 365,769 | $11.60 | $4.24MBuy |
| Column Group III GP LP | 10% Owner | 2025-03-26 | 344,827 | $11.60 | $4.00MBuy |
| Yang Li | Exec. Vice President Research | 2025-01-03 | 843 | $17.37 | $14.64kSell |
| Charles O. Williams | CFO and COO | 2025-01-03 | 1,181 | $17.37 | $20.51kSell |
SRZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SRZN insiders and whales buy or sell their stock.
SRZN Shareholders
What type of owners hold Surrozen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin Harold Livingston | 47.82% | 4,095,000 | $47.30M | Insider |
| Benny Soffer | 47.82% | 4,095,000 | $47.30M | Insider |
| Life Sciences Consonance | 47.82% | 4,095,000 | $47.30M | Insider |
| Mitchell J. Md Blutt | 30.88% | 2,644,000 | $30.54M | Insider |
| Column Group III GP LP | 21.54% | 1,844,570 | $21.30M | Insider |
| Tim Kutzkey | 21.54% | 1,844,570 | $21.30M | Insider |
| Column Group LLC | 17.52% | 1,499,773 | $17.32M | Institution |
| Stempoint Capital LP | 8.02% | 686,539 | $7.93M | Institution |
| Vr Adviser LLC | 7.39% | 632,931 | $7.31M | Institution |
| Ra Capital Management LP | 7.04% | 602,626 | $6.96M | Institution |
SRZN vs Biotech Stocks
Surrozen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.